UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000026150 |
|---|---|
| Receipt number | R000028606 |
| Scientific Title | Safety and efficacy of mexiletine hydrochroride in spinal and bulbar muscular atrophy (SBMA) :a multicenter, randomised, double-blind, placebo-controlled trial |
| Date of disclosure of the study information | 2017/03/31 |
| Last modified on | 2023/02/06 10:00:21 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/02/15 17:37:47 | ||
| 2 | Update | 2017/03/30 22:52:19 | Date of disclosure of the study information |
|
| 3 | Update | 2017/03/30 22:53:45 | Anticipated trial start date |
|
| 4 | Update | 2018/01/11 18:38:08 | Recruitment status |
|
| 5 | Update | 2018/08/20 13:21:17 | Recruitment status |
|
| 6 | Update | 2023/02/06 09:43:43 | Recruitment status Date of IRB Last follow-up date |
|
| 7 | Update | 2023/02/06 10:00:21 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
